会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 41. 发明专利
    • JPH089617B2
    • 1996-01-31
    • JP50186891
    • 1990-12-27
    • A61K31/52A61K9/02A61K9/08A61K9/10A61K9/48A61K31/522A61P9/04A61P9/08A61P11/08A61P37/08C07D239/54C07D473/04C07D473/06
    • Xanthines of the general formula: wherein R represents a straight or branched chain alkyl, alkenyl or alkynyl group of 3-6 carbon atoms, and R and R , which may be the same or different, each represent hydrogen or halogen or a methyl, methoxy, nitro or trifluoromethyl group or R and R together form a methylenedioxy or ethylenedioxy group; with the proviso that R and R are not both hydrogen; and pharmacologically acceptable salts thereof with an alkali metal base or a nitrogen base containing organic base, are bronchodilators making them of value in treating asthma and vasodilators making them of interest in treating angina, hypertension, congestive heart failure and multi-infarct dementia. The compounds are also of use in combatting other conditions where inhibition of PDE type IV is thought to be beneficial. The compounds can be prepared by treating the corresponding 6-amino uracil with sodium nitrite and formic acid in an excess of formamide and adding sodium dithionate to reduce the resulting 6-amino-5-nitroso compound to give the 5,6-diamino compound that ring closes with the excess of formamide.